PATENT CLAIM ANALYSIS

Application Number: 15989532
Application Type: Utility
Filing Date: 2018-05
Publication Date: 2018-09
Patent Classification: ["424", "136100"]

Abstract:
Bispecific EGFR/c-Met antibodies and methods of making and using the molecules.

Claim (Index 25):
The method of  claim 24 , wherein the EGFR activating mutation is G719A, G719X (X being any amino acid), L861X (X being any amino acid), L858R, E746K, L747S, E749Q, A750P, A755V, V765M, L858P or T790M substitution, deletion of E746-A750, deletion of R748-P753, insertion of Ala (A) between M766 and A767, insertion of Ser, Val and Ala (SVA) between S768 and V769, and insertion of Asn and Ser (NS) between P772 and H773.

Metadata:
- Claim Count in Document: 20.0
- Percentile: 93.0
- Lexical Diversity: 1.09091
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14283257', '15386195', '14086588', '14086250', '14085340']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8471907987048273
- 35 USC 102 Novelty (BERT): 0.7645611953384607
- Combined Prediction Score: 0.8389278383681906
- Mean Citation Score: 723.874022
- Max Citation Score: 927.17365
- Similarity Product: 893.4953034825265

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test